Attain Higher Yields and Faster Timelines for Your Biologics

Discover tailored solutions for your new therapeutic candidate, such as CAR Discovery, Monoclonal, Bispecific, or Tri-specific Antibodies, and Antibody-Drug Conjugates (ADCs), advancing discovery to the clinic with speed and reliability.

Generate fully human antibody leads quickly with hybridoma, phage display, a human antibody library, or single B cell screening, delivering the best candidates with the highest chance of success.

Optimize antibody candidates with humanization and affinity maturation to enhance developability, stability, efficacy, and manufacturability.

Leverage bespoke in vitro assays with 1,100+ successful projects for fast, precise pharmacology insights on your timeline in as little as 2 weeks.

Harness our in vivo pharmacology services to generate your PD, PK, and tox data, empowering confident go or no-go decisions in biologics development.

Achieve high titers and stable cell lines with ProCLD®, reaching up to 15 g/L for monoclonal antibodies Abs and 10 g/L for bispecific antibodies.

Accelerate your path to clinic with ProBio’s platform and rapid material supply, which supports your regulatory-filing enabling studies submissions. Our phase-appropriate CMC offerings optimize your path to tox supply and streamline your process through efficient study design, reliable materials generation, and data-driven decision-making.

Ensure process reliability with characterization and validation, enabling scalable, high-quality biologics manufacturing.

Support complex biologics with tailored bioanalytical assays for characterization, optimization, and regulatory compliance.

Utilize flexible 25L–2000L scales to produce GMP batches with industry-leading titers, delivering quality for clinical and commercial needs.

Streamline development with high-speed aseptic liquid and lyophilized fill-finish solutions, providing reliable biologics drug supply for sponsors, and high-quality biologics at every stage.